Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50